Can the Side Effects of Mydriatics Be Reduced with the ROP-bundle Protocol?
Aim:The mydriatics that used for pupil-dilation in the examination of retinopathy-of-prematurity (ROP) may cause some side-effects in the neurological, gastrointestinal, cardiovascular systems by absorption from the nasal mucosa, cornea, conjunctiva, skin. In order to minimize these side-effects, it...
Main Authors: | Özlem ŞAHİN, Özmert M.A. ÖZDEMİR, Ebru Nevin ÇETİN, Kazım KÜÇÜKTAŞÇI, Hacer ERGİN |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayincilik
2023-09-01
|
Series: | Namık Kemal Tıp Dergisi |
Subjects: | |
Online Access: |
http://namikkemalmedj.com/archives/archive-detail/article-preview/can-the-side-effects-of-mydriatics-be-reduced-with/62104
|
Similar Items
-
Retinopathy of prematurity (ROP): From the perspective of the neonatologist
by: Esin Koc, et al.
Published: (2024-06-01) -
Incidence of Retinopathy of Prematurity (ROP) in Low Birth Weight Newborns
by: Reza Saeidi, et al.
Published: (2017-12-01) -
Comparison of effects of mydriatic drops (1% cyclopentolate and 0.5% tropicamide) on anterior segment parameters
by: Yelda Yildiz Tasci, et al.
Published: (2021-01-01) -
Bronchoconstriction following instillation of phenylephrine eye drops in premature infants with bronchopulmonary dysplasia: two cases report
by: Hyun Jee Kim, et al.
Published: (2015-12-01) -
Screening for ROP
by: Graham Quinn, et al.
Published: (2017-11-01)